Development of retro-inverso peptides as anti-aggregation drugs for β-amyloid in Alzheimer's disease

Peptides

Volumn 31, Issue 10, 2010, Pages 1866-1872

  Matharu, Balpreet ^a   El Agnaf, Omar ^b   Razvi, Amna ^a   Austen, Brian M ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

Author keywords

Amyloid; Aggregation; Alzheimer's disease

Indexed keywords

AMYLOID BETA PROTEIN; ARGINYLGLYCYLPHENYLALANYLPHENYLALANYLVALYLLEUCYLLYSYLGLYCYLARGININAMIDE; GLUTAMINYLLYSYLLEUCYLVALYLPHENYLALANYLPHENYLALANYLGLYCINAMIDE; PEPTIDE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG INHIBITION; DRUG SYNTHESIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; AMYLOID BETA-PEPTIDES; ANIMALS; CELL LINE, TUMOR; HUMANS; MOLECULAR SEQUENCE DATA; NEURONS; NEUROPROTECTIVE AGENTS; PEPTIDE FRAGMENTS; PEPTIDES; PROTEIN BINDING;

EID: 77956681609     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2010.06.033     Document Type: Article

References (18)

1. B.M. Austen, O.M. El-Agnaf, B. Maltharu, and N. Gunasekera Retroinverso peptides inhibit amyloid neurotoxicity and are potential therapeutics against Alzheimer's disease J Pep Sci 12 2006 208 1208
2. B.M. Austen, K.E. Paleologou, A.E. Sumaya, M.M. Qureshi, D. Allsop, and O.M.A. El-Agnaf Designing peptide inhibitors for oligomerisation and toxicity of Alzheimer's β-amyloid peptide Biochemistry 47 2008 1984 1992
3. F.E. Cohen, and J.W. Kelly Therapeutic approaches to protein-misfolding diseases Nature 426 2005 905 909
4. M.A. El-Agnaf, H. Goodwin, J.M. Sheridan, E.R. Frears, and B.M. Austen Improved solid-phase syntheses of amyloid proteins associated with neurodegenerative diseases Pept Prot Lett 7 2000 1 8
5. O.M. El-Agnaf, D.S. Mahil, B.P. Patel, and B.M. Austen Oligomerization and toxicity of β-amyloid-42 implicated in Alzheimer's disease Biochem Biophys Res Commun 273 2000 1003 1007
6. T.K. Gibson, and R.M. Murphy Design of peptide inhibitors that affect β-amyloid aggregation: importance of surface tension and context Biochemistry 44 2005 8898 8907
7. B. Godber, K.S. Thompson, M. Rehak, Y. Uludag, S. Kelling, A. Slepstov, M. Frogley, K. Wiehler, C Whalen, and M.A. Cooper Direct quantification of analyte concentration by resonant acoustic profiling Clin Chem 51 2005 1962 1972
8. M. Goodman, and M. Chorev On the concept of linear modified retro-peptide structures Acc Chem Res 12 1979 1 7
9. K.K. Kandimalla, G.L. Curran, S.S. Holasek, E.J. Gilles, T.M. Wengenack, M. Ramirez-Alvarado, and J.F. Poduslo Physiological and biophysical factors that influence Alzheimer's disease amyloid plaque targeting of native and putrescine modified human amyloid beta J Pharmacol Exp Ther 318 2006 17 25
10. B. Matharu, G. Gibson, R. Parsons, T.N. Huckerby, S.A. Moore, L.J. Cooper, R. Millichamp, D. Allsop, and B. Austen Galantamine inhibits beta-amyloid aggregation and cytotoxicity J Neurol Sci 280 2009 49 58 Epub 2009 Feb 26
11. L. Ritter, D. Riek-Loher, B. Bohrmann, H. Dobeli, and R. Riek 3D structure of Alzheimer's amyloid-beta-(1-42) fibrils Proc Natl Acad Sci 102 2005 17342 17347
12. D. Schenk, R. Barbour, and W. Dunn Immunization with amyloid-β attenuates Alzheimer-like pathology in the PDAPP mice Nature 400 1999 173 177
13. A.K. Sian, E.R. Frears, O.M.A. El-Agnaf, B.P. Patel, M.F. Manca, G. Siligardi, R. Haussain, and B.M. Austen Oligomerisation of β-Amyloids of the Alzheimer's and the Dutch cerebral haemorrhage types Biochem J 349 2000 299 308
14. C. Soto, E.M. Sigurdsson, L. Morelli, R.A. Kumzar, E.M. Castano, and B. Frangione β-Sheet breaker peptides inhibit fibrillogensis in a rat brain model of amyloidosis; implications for Alzheimer's Therapy Nat Med 4 1998 822 826
15. D.J. Stephens, and B.M. Austen Metabolites of the beta-amyloid precursor protein generated by beta-secretase localise to the trans-Golgi network and late endosome in 293 cells J Neurosci Res 46 1996 211 225
16. E. Terzi, G. Hölzemann, and J. Seelig Self-association of beta-amyloid peptide (1-40) in solution and binding to lipid membranes J Mol Biol 252 1995 633 642
17. L.O. Tjernberg, J. Naslund, F. Lindqvist, J. Johansson, A.R. Karlstrom, J. Thyberg, L. Terenius, and C. Nordstedt Arrest of β-amyloid fibril formation by a pentapeptide ligand J Biol Chem 271 1996 8545 8548
18. D.M. Walsh, and D.J. Selkoe A beta oligomers - a decade of discovery J Neurochem 101 2007 1172 1184